A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells

Molecular Endocrinology

Volumn 13, Issue 12, 1999, Pages 2122-2136

  Chien, Pei Yu ^a   Ito, Masafumi ^a   Park, Youngkyu ^a   Tagami, Tetsuya ^a   Gehm, Barry D ^a   Jameson, J Larry ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CELL NUCLEUS RECEPTOR; CHIMERIC PROTEIN; ESTROGEN RECEPTOR; HISTONE DEACETYLASE; HYBRID PROTEIN; LIGAND; NUCLEAR RECEPTOR COREPRESSOR; RETINOIC ACID; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CARCINOMA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE INSERTION; GENE REPRESSION; GENE SILENCING; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; REPRESSOR GENE; TRANSCRIPTION REGULATION;

EID: 0033306892     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.12.0394     Document Type: Article

References (99)

1. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
2. Estrogen response elements function as allosteric modulators of estrogen receptor conformation
3. Functional domains of the human estrogen receptor
4. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
5. Sequence and expression of human estrogen receptor complementary DNA
6. Cloning of a novel receptor expressed in rat prostate and ovary
7. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
8. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
9. Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator
10. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
11. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
12. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
13. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
14. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
15. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
16. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
17. Role of CBP/P300 in nuclear receptor signalling
18. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
19. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
20. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors
21. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
22. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphoryiation of activation function AF-1
23. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
24. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
25. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
26. The CBP co-activator is a histone acetyltransferase
27. The transcriptional coactivators p300 and CBP are histone acetyltransferases
28. Steroid receptor coactivator-1 is a histone acetyltransferase
29. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro
30. A positive role for histone acetylation in transcription factor access to nucleosomal DNA
31. Histone acetylation: Influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression
32. Acetylation of general transcription factors by histone acetyltransferases
33. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
34. A transcriptional co-repressor that interacts with nuclear hormone receptors
35. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers
36. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
37. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
38. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
39. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3
40. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription
41. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
42. Linking histone acetylation to transcriptional regulation
43. Histone acetylation in chromatin structure and transcription
44. Chromatin and transcription-how transcription factors battle with a repressive chromatin environment
45. Chromatin remodeling regulated by steroid and nuclear receptors
46. Histone acetylation and transcriptional regulatory mechanisms
47. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
48. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
49. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens
50. Mechanisms of tamoxifen resistance
51. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action
52. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors
53. Powerful dominant negative mutants of the human estrogen receptor
54. Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness
55. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
56. Proteasomal regulation of nuclear receptor corepressor-mediated repression
57. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor
58. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
59. Structure and specificity of nuclear receptor-coactivator interactions
60. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
61. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements
62. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element
63. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes
64. Identification of two transactivation domains in the mouse oestrogen receptor
65. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase
66. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function
67. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells
68. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression
69. Retinoblastoma protein recruits histone deacetyiase to repress transcription
70. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors
71. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators
72. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone
73. The human estrogen receptor has two independent nonacidic transcriptional activation functions
74. Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists
75. The carboxy-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
76. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
77. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
78. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction
79. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation
80. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist
81. Thyroid hormone aporeceptor represses T3-inducibie promoters and blocks activity of the retinoic acid receptor
82. Modular structure of a chicken lysozyme silencer: Involvement of an unusual thyroid hormone receptor binding site
83. Moderate increase in histone acetylation activities the mouse mammary tumor virus promoter and remodels its nucleosome structure
84. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression
85. The retinoblastoma protein and cell cycle control
86. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
87. Rb interacts with histone deacetylase to repress transcription
88. Mechanism of active transcriptional repression by the retinoblastoma protein
89. The corepressor N-CoR and its variants RIP13a and RIP13 1 directly interact with the basal transcription factors TFIIB, TAF(II)32 and TAF(II)70
90. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
91. Second zinc finger mutants of thyroid hormone receptor selectively preserve DNA binding and heterodimerization but eliminate transcriptional activation
92. The thyroid hormone receptor variant α2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors
93. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
94. Panning transfected cells for electrophysiological studies
95. Thyroid hormone receptor mutants that cause resistance to thyroid hormone. Evidence for receptor competition for DNA sequences in target genes
96. Regulation of the human chorionic gonadotropin α- and β-subunit promoters by AP-2
97. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor
98. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells
99. Steroid hormone receptors: Basic principles and measurement